NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Antarka

Antarka

Private
MontevideoHealthcare & Life Scienceshttps://antarka.com/

Last Round

Seed

Mar 4, 2026

Total Funding Raised

$3.95M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Antarka is a biotechnology company that develops patented, Antarctic-derived enzymes for advanced skin repair and longevity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Advanced Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

cosmetic active ingredientDNA repairB2B ingredientbiotechnologyphotoagingcellular repaircosmeceutical ingredientextremophile enzymeUV damage repairbioactive ingredientdermocosmeticsanti-aging ingredientscience-backed skincareAntarctic biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antarka Comparables

Compare Antarka with similar companies based on industry and business-model similarity.

Antarka comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Croda International
72%
Vytrus Biotech S.A.
71%
bitop AG
71%

Antarka Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 4, 2026
AcceleratorOct 14, 2025

Key People

Founding team and executive leadership

Célica Cagide

Co-Founder & COO, Co-founder & COO

Founding Team

Stefano Valdesolo

Co-Founder & CEO

Founding Team

Antarka Investors

Notable investors and investment history

Antarka investors
InvestorRounds
Zentynel Frontier InvestmentsSeed
GS FuturesSeed
GRIDXAccelerator
AIR CapitalSeed
Agencia Nacional de Investigación e InnovaciónGrant
SOSVSeed, Accelerator
Vox CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    $4M round led by Natura Ventures and Zentynel Frontier Investments.

  • Oct 14, 2025

    $250K round led by SOSV

Antarka Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Antarka Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antarka's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontevideo
Employee Range8
Year Founded2023
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.